Market closed
SurModics/$SRDX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About SurModics
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
Ticker
$SRDX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
376
Website
SurModics Metrics
BasicAdvanced
$559M
Market cap
-
P/E ratio
-$0.82
EPS
1.20
Beta
-
Dividend rate
Price and volume
Market cap
$559M
Beta
1.2
52-week high
$42.44
52-week low
$25.17
Average daily volume
233K
Financial strength
Current ratio
3.958
Quick ratio
3.08
Long term debt to equity
24.857
Total debt to equity
24.857
Interest coverage (TTM)
-0.54%
Management effectiveness
Return on assets (TTM)
-0.66%
Return on equity (TTM)
-9.67%
Valuation
Price to revenue (TTM)
4.397
Price to book
4.67
Price to tangible book (TTM)
10.96
Price to free cash flow (TTM)
-170.892
Growth
Revenue change (TTM)
-4.91%
Earnings per share change (TTM)
645.45%
3-year revenue growth (CAGR)
6.24%
3-year earnings per share growth (CAGR)
39.82%
What the Analysts think about SurModics
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for SurModics stock.
SurModics Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
SurModics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
SurModics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for SurModics stock?
SurModics (SRDX) has a market cap of $559M as of November 22, 2024.
What is the P/E ratio for SurModics stock?
The price to earnings (P/E) ratio for SurModics (SRDX) stock is 0 as of November 22, 2024.
Does SurModics stock pay dividends?
No, SurModics (SRDX) stock does not pay dividends to its shareholders as of November 22, 2024.
When is the next SurModics dividend payment date?
SurModics (SRDX) stock does not pay dividends to its shareholders.
What is the beta indicator for SurModics?
SurModics (SRDX) has a beta rating of 1.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.